Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-010648
Filing Date
2019-04-15
Accepted
2019-04-15 17:31:34
Documents
2
Period of Report
2019-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5752
2 EX-24 DOCUMENT attachment1.htm EX-24 4358
  Complete submission text file 0000899243-19-010648.txt   11506
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014
Business Address
Sadr Ahmad (Reporting) CIK: 0001773641 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 19749374